TSC2 Deficiency Unmasks a Novel Necrosis Pathway That Is Suppressed by the RIP1/RIP3/MLKL Signaling Cascade.

Tuberous sclerosis complex (TSC) is a genetic multiorgan disorder characterized by the development of neoplastic lesions in kidney, lung, brain, heart, and skin. It is caused by an inactivating mutation in tumor suppressor genes coding the TSC1/TSC2 complex, resulting in the hyperactivation of mTOR- and Raf/MEK/MAPK-dependent signaling that stimulates tumor cell proliferation and metastasis. Despite its oncogenic effect, cells with TSC deficiency were more sensitive to oxidative stress and dependent on mitochondrial metabolism, providing a rationale for a new therapeutic approach. The current study shows that simultaneous inhibition of two major pathways regulating redox homeostasis using l-buthionine-sulfoximine (BSO, glutathione synthesis inhibitor) and auranofin (thioredoxin reductase inhibitor) induces oxidative burst, mitochondrial damage, and necrotic cell death in TSC-deficient cells in a highly synergistic and cell context-specific manner. Furthermore, blocking RIP1/RIP3/MLKL-dependent signaling using chemical inhibitors necrostatin-1 (Nec-1) and necrosulfonamide (NSA) synergizes with BSO and auranofin in killing TSC-deficient cells. Expression analysis demonstrated that RIP1, RIP3, and MLKL protein levels are elevated in cells with TSC2 deficiency, and their inactivation enhances mitochondrial dysfunction in a glutaminolysis-dependent and autophagy-independent manner. Finally, supplementation with the mitochondrial metabolite α-ketoglutarate, whose synthesis is regulated by RIP1/RIP3/MLKL, rescues cells from the sensitizing effect of Nec-1 and NSA. Together, this study identifies a previously unrecognized novel regulated necrotic death pathway that involves mitochondrial homeostasis, is suppressed by the RIP1/RIP3/MLKL signaling in TSC-deficient cells, and could be a promising therapeutic target for TSC-associated tumors. Cancer Res; 76(24); 7130-9. ©2016 AACR.

National Particle Component Toxicity (NPACT) initiative report on cardiovascular effects.

Epidemiologic and toxicologic studies were carried out in concert to provide complementary insights into the compositional features of ambient particulate matter (PM*) that produce cardiovascular effects. In the epidemiologic studies, we made use of cohort data from two ongoing studies--the Multi-Ethnic Study of Atherosclerosis (MESA) and the Women's Health Initiative--Observational Study (WHI-OS)--to investigate subclinical markers of atherosclerosis and clinical cardiovascular events. In the toxicologic study, we used the apolipoprotein E null (ApoE(-/-)) hypercholesterolemic mouse model to assess cardiovascular effects of inhalation exposure to various atmospheres containing laboratory-generated pollutants. In the epidemiologic studies, individual-level residential concentrations of fine PM, that is, PM with an aerodynamic diameter of 2.5 microm or smaller (PM2.5), PM2.5 components (primarily elemental carbon [EC] and organic carbon [OC], silicon, and sulfur but also sulfate, nitrate, nickel, vanadium, and copper), and the gaseous pollutants sulfur dioxide and nitrogen dioxide were estimated using spatiotemporal modeling and other exposure estimation approaches. In the MESA cohort data, evidence for associations with increased carotid intima-media thickness (CIMT) was found to be strongest for PM2.5, OC, and sulfur, as well as for copper in more limited analyses; the evidence for this was found to be weaker for silicon, EC, and the other components and gases. Similarly, in the WHI-OS cohort data, evidence for associations with incidence of cardiovascular mortality and cardiovascular events was found to be good for OC and sulfur, respectively, and for PM2.5; the evidence for this was found to be weaker for EC and silicon. Source apportionment based on extensive monitoring data in the six cities in the MESA analyses indicated that OC represented secondary formation processes as well as primary gasoline and biomass emissions, that sulfur represented largely secondary inorganic aerosols, and that copper represented brake dust and diesel emissions. In the toxicologic study, hypercholesterolemic mice were exposed for 50 days to atmospheres containing mixed vehicular engine emissions (MVE) consisting of mixed gasoline and diesel engine exhaust or to MVE-derived gases only (MVEG). Mice were also exposed to atmospheres containing sulfate, nitrate, or road dust, either alone or mixed with MVE or MVEG. Sulfate alone or in combination with MVE was associated with increased aortic reactivity. All exposures to atmospheres containing MVE (including a combination of MVE with other PM) were associated with increases in plasma and aortic oxidative stress; exposures to atmospheres containing only sulfate or nitrate were not. Exposure to MVE and to MVEG combinations except those containing road dust resulted in increased monocyte/macrophage sequestration in aortic plaque (a measure of plaque inflammation). Exposure to all atmospheres except those containing nitrate was associated with enhanced aortic vasoconstriction. Exposure to the MVEG was an independent driver of lipid peroxidation, matrix metalloproteinase (MMP) activation, and vascular inflammation. The epidemiologic and toxicologic study designs were intended to complement each other. The epidemiologic studies provided evidence in real-world human settings, and the toxicologic study directly assessed the biologic effects of various pollutant mixtures (in a way that is not possible in epidemiologic studies) by examining endpoints that probably underlie the subclinical and clinical cardiovascular endpoints examined in the epidemiologic studies. The epidemiologic studies were not suited to determining whether the observed associations were caused by direct effects of individual pollutants or by the mixtures in which individual pollutants are found. These studies were consistent in finding that OC and sulfate had the strongest evidence for associations with the cardiovascular disease endpoints, with much weaker evidence for EC and silicon. Both OC and sulfate reflected a large secondary aerosol component. Results from the toxicologic study indicated, for the most part, that MVE and mixtures of MVE and MVEG with other PM pollutants were important in producing the toxic cardiovascular effects found in the study. Further work on the effects of pollutant mixtures and secondary aerosols should allow better understanding of the pollution components and sources most responsible for the adverse cardiovascular effects of air pollution exposure.

Inhalation administration of all-trans-retinoic acid for treatment of elastase-induced pulmonary emphysema in Fischer 344 rats.

A past study demonstrated that all-trans-retinoic acid (ATRA) treatment by intraperitoneal injection in a rat model of elastase-induced emphysema caused tissue regeneration as evidenced by a decrease in alveolar size and lung volume and an increase in alveolar number. We postulated that treatment with this retinoid by nose-only inhalation exposure would be a more efficient means of targeting damaged lung tissue. Emphysema was induced in male Fischer 344 rats by intratracheal instillation of pancreatic elastase (0.5 IU/g body weight). Four weeks after elastase instillation, animals were treated once daily, 4 days/week, for 3 weeks by exposing them nose-only to aerosolized ATRA (target concentration-time of 3000 or 15,000 mg-min/m3) or by injecting them intraperitoneally with ATRA in cottonseed oil (0.5 or 2.5 mg/kg). Based on estimates of particle deposition in the respiratory tract, inhalation doses were chosen to be consistent with injected doses. Lungs were fixed by inflation with formalin (constant pressure for 6 hours followed by >48 hours of immersion) and were embedded in paraffin. Sections were evaluated by histopathology and stereology. Inhalation exposure to ATRA at both aerosol concentrations caused significant elevations of ATRA in the lung, whereas only the high-dose injection treatment was associated with an elevation of lung ATRA. The mean ATRA concentration from lungs of rats in the high-dose inhalation exposure groups as measured by liquid chromatography--mass spectrometry was approximately 12-fold greater than that of high-dose injection-treated rats. Elastase instillation caused increased lung volumes, irregular alveolar air space enlargement, and fragmentation and attenuation of alveolar septa. Neither inhaled nor injected ATRA reduced the enlarged lung volumes associated with this emphysema model. Stereology demonstrated that alveolar air space enlargement in ATRA-treated rats was similar to that in sham-treated emphysematous animals. Thus, while inhalation treatment caused greater levels of the drug in lung tissue in comparison to that of injection-treated animals, treatment with ATRA by either route of administration did not cause a reversal of lung tissue damage in this model of elastase-induced emphysema.